Kyverna Therapeutics (KYTX) Earnings Date, Estimates & Call Transcripts → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free KYTX Stock Alerts $14.74 -0.68 (-4.41%) (As of 01:21 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 14) -$1.12 Missed By -$0.28 Consensus EPS (May. 14) -$0.84 Get Kyverna Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for KYTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKYTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KYTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Kyverna Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($1.20)($1.20)($1.20)Q2 20241($0.69)($0.69)($0.69)Q3 20241($0.83)($0.83)($0.83)Q4 20241($0.98)($0.98)($0.98)FY 20244($3.70)($3.70)($3.70)KYTX Earnings Date and InformationKyverna Therapeutics last posted its earnings data on May 14th, 2024. The reported ($1.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.84) by $0.28. Kyverna Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Kyverna Therapeutics are expected to decrease in the coming year, from ($3.34) to ($4.11) per share. Kyverna Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Kyverna Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/14/2024Q1 2024($0.84)($1.12)($0.28)($1.12)$3.75 million- Kyverna Therapeutics Earnings - Frequently Asked Questions When is Kyverna Therapeutics's earnings date? Kyverna Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on KYTX's earnings history. Did Kyverna Therapeutics beat their earnings estimates last quarter? In the previous quarter, Kyverna Therapeutics (NASDAQ:KYTX) missed the analysts' consensus estimate of ($0.84) by $0.28 with a reported earnings per share (EPS) of ($1.12). Learn more on analysts' earnings estimate vs. KYTX's actual earnings. How much revenue does Kyverna Therapeutics generate each year? Kyverna Therapeutics (NASDAQ:KYTX) has a recorded annual revenue of $7.03 million. How much profit does Kyverna Therapeutics generate each year? Kyverna Therapeutics (NASDAQ:KYTX) has a recorded net income of -$60.37 million. KYTX has generated $0.00 earnings per share over the last four quarters. What is Kyverna Therapeutics's EPS forecast for next year? Kyverna Therapeutics's earnings are expected to decrease from ($3.34) per share to ($4.11) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Humacyte Earnings Date ProKidney Earnings Date Cabaletta Bio Earnings Date Exscientia Earnings Date Valneva Earnings Date Alector Earnings Date Allogene Therapeutics Earnings Date Adaptive Biotechnologies Earnings Date Editas Medicine Earnings Date Voyager Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:KYTX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
